Expert Commentary

What is the ideal treatment timing for bisphosphonate therapy?

Author and Disclosure Information

WHAT DOES THIS MEAN FOR PRACTICE?

  • Oral bisphosphonates remain in our armamentarium for reducing fracture in postmenopausal patients

  • Ideal duration of therapy remains unclear

  • Counsel patients: up to 2 y of therapy reduces fracture risk; >10 y of therapy may increase fracture risk


 

   Comments ()

Recommended for You

Reviews and Expert Commentary

Quizzes from MD-IQ

Research Summaries from ClinicalEdge

Next Article: